Authors: PAWLIK CA ISRAEL M SWEATMAN TW LOTHSTEIN L

Citation: Ca. Pawlik et al., CELLULAR-RESISTANCE AGAINST THE NOVEL HYBRID ANTHRACYCLINE N-(2-CHLOROETHYL)-N-NITROSOUREIDODAUNORUBICIN (AD-312) IS MEDIATED BY COMBINED ALTERED TOPOISOMERASE-II AND O-6-METHYLGUANINE-DNA METHYLTRANSFERASE ACTIVITIES, Oncology research, 10(4), 1998, pp. 209-217

Authors: LOTHSTEIN L RODRIGUES PJ SWEATMAN TW ISRAEL M

Citation: L. Lothstein et al., CYTOTOXICITY AND INTRACELLULAR BIOTRANSFORMATION OF N-BENZYLADRIAMYCIN-14-VALERATE (AD-198) ARE MODULATED BY CHANGES IN 14-O-ACYL CHAIN-LENGTH, Anti-cancer drugs, 9(1), 1998, pp. 58-66

Authors: HAN GZ ISRAEL M SESHADRI R DALTON JT SWEATMAN TW

Citation: Gz. Han et al., PHARMACOLOGY OF N,N-DI(N-BUTYL)ADRIAMYCIN-14-VALERATE IN THE RAT, Cancer chemotherapy and pharmacology, 37(5), 1996, pp. 472-478

Authors: LOTHSTEIN L SWEATMAN TW PRIEBE W

Citation: L. Lothstein et al., HYDROXYLATION AT C-3' OF DOXORUBICIN ALTERS THE SELECTED PHENOTYPE OFCELLULAR-DRUG RESISTANCE, Bioorganic & medicinal chemistry letters, 5(16), 1995, pp. 1807-1812

Authors: LOTHSTEIN L KOSEKI Y SWEATMAN TW

Citation: L. Lothstein et al., P-GLYCOPROTEIN OVEREXPRESSION IN MOUSE CELLS DOES NOT CORRELATE WITH RESISTANCE TO N-BENZYLADRIAMYCIN-14-VALERATE (AD-198), Anti-cancer drugs, 5(6), 1994, pp. 623-633

Authors: LOTHSTEIN L HOSEY LM SWEATMAN TW KOSEKI Y DOCKTER M PRIEBE W

Citation: L. Lothstein et al., N-BENZYLADRIAMYCIN-14-VALERATE (AD-198)-RESISTANT CELLS EXHIBIT HIGHLY SELECTIVE CROSS-RESISTANCE TO OTHER ANTHRACYCLINES THAT CIRCUMVENT MULTIDRUG-RESISTANCE, Oncology research, 5(6-7), 1993, pp. 229-234